United States · FDA National Drug Code directory
ISOVUE 300
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0270-1315_2cb2e0be-08b1-e446-01c5-b1c50f1e797c
- Product NDC
- 0270-1315
- Form
- INJECTION, SOLUTION
- Composition / generic term
- IOPAMIDOL
- Labeler
- BRACCO DIAGNOSTICS INC
- Marketing category
- NDA
- Marketing start / end (source format)
- 19851231
- Source listing expiry
- 20271231
Source-listed ingredients
- IOPAMIDOL — 612 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 BOX (0270-1315-25) / 30 mL in 1 VIAL, SINGLE-DOSE · 0270-1315-25
- 10 VIAL, SINGLE-DOSE in 1 BOX (0270-1315-30) / 50 mL in 1 VIAL, SINGLE-DOSE · 0270-1315-30
- 10 BOTTLE in 1 BOX (0270-1315-35) / 100 mL in 1 BOTTLE · 0270-1315-35
- 10 BOTTLE in 1 BOX (0270-1315-50) / 150 mL in 1 BOTTLE · 0270-1315-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →